Available Guidelines: ESMO Guidelines

europeanunion Go back to Compilation: ESMO Guidelines (European Union) page

Source: Click here to learn more.

Breast Cancer:

• Metastatic Breast Cancer
• Breast cancer in the COVID-19 era
• Consensus Recommendations – Breast Cancer in Young Women (BCY5)
• Early Breast Cancer
• Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes

Cancers of Unknown Primary Site:

• Cancers of Unknown Primary Site

Endocrine and Neuroendocrine Cancers:

• Adrenocortical Carcinomas and Malignant Phaeochromocytomas
• Gastroenteropancreatic Neuroendocrine Neoplasms
• Lung and Thymic Carcinoids
• Thyroid cancer

Gastrointestinal Cancers:

• Anal Cancer
• Biliary Tract Cancer
• Gastric Cancer
• Gastrointestinal cancers: Colorectal cancer (CRC) in the COVID-19 era
• Gastrointestinal cancers: Gastro-oesophageal tumours in the COVID-19 era
• Gastrointestinal cancers: Pancreatic cancer in the COVID-19 era
• Hepatocellular Carcinoma
• Hereditary Gastrointestinal Cancers
• Localised Colon Cancer
• Metastatic Colorectal Cancer
• Oesophageal Cancer; Pancreatic Cancer
• Rectal Cancer

Genitourinary Cancers:

• Bladder Cancer
• Penile Carcinoma
• Prostate Cancer
• Renal Cell Carcinoma
• Testicular Cancer

Gynaecological Cancers:

• Cervical Cancer
• Endometrial Cancer
• Gestational Trophoblastic Disease
• Gynaecological malignancies: Cervical cancer in the COVID-19 era
• Gynaecological malignancies: Endometrial cancer in the COVID-19 era
• Gynaecological malignancies: Epithelial ovarian cancer in the COVID-19 era
• Newly Diagnosed and Relapsed Epithelial Ovarian Carcinoma
• Non-Epithelial Ovarian Cancer
• Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes

Haematological Malignancies:

• Acute Lymphoblastic Leukaemia
• Acute Myeloid Leukaemia
• Chronic Lymphocytic Leukaemia
• Chronic Myeloid Leukaemia
• Diffuse Large B-Cell Lymphoma
• Elderly Patient with Malignant Lymphoma
• Extranodal Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma
• Follicular Lymphoma
• Hairy Cell Leukaemia
• Hodgkin Lymphoma
• Management of ultra-high-risk Patients
• Mantle Cell Lymphoma
• Marginal Zone Lymphomas
• Multiple Myeloma
• Myelodysplastic Syndromes
• Peripheral T-Cell Lymphomas
• Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms
• Primary Cutaneous Lymphoma
• Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia
• Waldenstrom’s Macroglobulinaemia

Head and Neck Cancers:

• Nasopharyngeal Carcinoma
• Salivary Gland Cancer
• Squamous Cell Carcinoma of the Head and Neck

Hereditary Syndromes:

• Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes
• Hereditary Gastrointestinal Cancers

Lung and Chest Tumours:

• Early-Stage and Locally Advanced (non-metastatic) Non-Small-Cell Lung Cancer
• Lung cancer in the COVID-19 era; Malignant Pleural Mesothelioma
• Non-Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer
• Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer
• Small-Cell Lung Cancer
• Thymic Epithelial Tumours

Melanoma:

• Cutaneous Melanoma

Neuro-Oncology:

• Leptomeningeal Metastasis
• High-Grade Malignant Glioma
• Neurological and Vascular Complications of Primary and Secondary Brain Tumours
• Brain Metastasis from Solid Tumours

Sarcoma and GIST:

• Bone Sarcomas
• Soft Tissue and Visceral Sarcomas
• Gastrointestinal Stromal Tumours

Supportive and Palliative Care:

• Palliative Care in the COVID-19 era
• Advanced Care Planning
• Anxiety and Depression
• Anaemia and Iron Deficiency in Patients With Cancer
• Bone Health in Cancer Patients
• Cancer Cachexia in Adult Patients
• Cancer Pain
• Cancer-related Fatigue
• Care at the End of Life
• Central Venous Access in Oncology
• Chemotherapy Extravasation
• Constipation in Advanced Cancer
• Delirium in Adult Cancer Patients
• Diarrhoea in Adult Cancer Patients
• Febrile Neutropaenia
• Fertility Preservation and Post-treatment Pregnancies in Post-pubertal Cancer Patients
• Infusion Reactions to Systemic Anticancer Therapy
• Management of Breathlessness in Patients with Cancer
• Management of Cardiac Disease; Management of Orphan Symptoms
• Neurotoxicity; Oral and Gastrointestinal Mucosal Injury
• Prevention and Management of Dermatological Toxicities Related to Anticancer Agents
• Prevention of Chemotherapy and Radiotherapy-Induced Nausea and Vomiting
• Prognostic Evaluation in Advanced Cancer
• Role of Patient-reported Outcome Measures
• Toxicities from immunotherapy and Venous Thromboembolism in Cancer Patients